Analyst Mike Matson works at NEEDHAM and is focused on the Healthcare sector with 982 price targets and ratings documented since 2013 spanning on 34 stocks. Analyst's average stock valuation to be materialised ratio is 58.28% with an average time for price targets to be met of 286.5 days.
Most recent stock forecast was given on CNMD, CONMED Corporation at 15-Nov-2022.
Mike Matson best performing recommendations are on VCYT (VERACYTE, INC).
The best stock recommendation documented was for VCYT (VERACYTE, INC) at 11/3/2020. The price target of $40 was fulfilled within 1 day with a profit of $1.78 (4.66%) receiving and performance score of 46.57.
Average potential price target upside